Trial ID or NCT#

NCT02165839

Status

not recruiting iconNOT RECRUITING

Purpose

PRIMARY OBJECTIVE(S): To evaluate the efficacy of the Brief Behavioral Therapy for Insomnia (BBT-I) in treating insomnia among breast cancer patients receiving chemotherapy. SECONDARY OBJECTIVE(S): - To evaluate the efficacy of the BBT-I in treating cancer-related symptoms such as cancer-related fatigue and cognitive difficulties in breast cancer patients receiving chemotherapy. - To examine potential moderators and mediators of BBT-I intervention effects on insomnia, cognitive difficulties, and fatigue. In particular, we are interested in age, depression and anxiety and side effects (hot flashes) as potential moderators of the intervention effects as well as evaluating modifiable behavioral and physiological mechanisms as hypothesized mediators

Official Title

Brief Behavioral Intervention for Insomnia During Chemotherapy

Eligibility Criteria

Ages Eligible for Study: Older than 21 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No

Investigator(s)

Oxana Palesh
Oxana Palesh
Psychologist
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Clete A. Kushida, MD, PhD
Clete A. Kushida, MD, PhD
Sleep specialist, Neurologist
Professor of Psychiatry and Behavioral Sciences
Douglas W. Blayney
Douglas W. Blayney
Medical oncologist, Breast specialist
Professor of Medicine (Oncology)

Contact us to find out if this trial is right for you.

CONTACT

Oxana Palesh
(650) 725-7011